TABLE 4

Comparison of Facilitating Experiences: Continuers Versus Discontinuers

ExperiencesContinuers (n = 16)Discontinuers (n = 20)
Good communication with health care team
• My health care team explained that GLP-1 receptor agonist therapy would improve my blood glucose control.13 (81.3)12 (60.0)
• My health care team explained why my GLP-1 receptor agonist medication needs to be taken as an injectable.12 (75.0)15 (75.0)
• My health care team explained the importance of gradual dosage titration.12 (75.0)10 (50.0)
• My health care team explained how to manage food volume and fats.7 (43.8)7 (35.0)
Access to information
• My questions about medications were answered by my health care team when I started on GLP-1 receptor agonist therapy.15 (93.8)15 (75.0)
• I was provided information about GLP-1 receptor agonist medications.15 (93.8)12 (60.0)
• I was provided general information about diabetes.12 (75.0)14 (70.0)
• My physician’s office called to check on my progress and ask if I had any additional questions.10 (62.5)8 (40.0)
  • Data are n (%).